Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequential Infusion of Unmanipulated Donor Lymphocytes and Cytokine Induced Killer (CIK)Cells After Allogeneic Stem Cell Transplantation

NCT01186809 is registered in ClinicalTrials.gov with A.O. Ospedale Papa Giovanni XXIII as lead sponsor.

NCT NCT01186809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01186809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequential Infusion of Unmanipulated Donor Lymphocytes and Cytokine Induced Killer (CIK)Cells After Allogeneic Stem Cell Transplantation
Lead sponsor
A.O. Ospedale Papa Giovanni XXIII
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2009
Completion date
May 15, 2017
Enrollment
74 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancies